
Sovihep D Tablet - Sofosbuvir & Daclatasvir Composition | Effective Treatment For Chronic Hepatitis C, Reduces Infection, Prevents Liver Issues
Price: 17450 INR / Bottle
Get Latest Price
Minimum Order Quantity :
50 Bottle
In Stock
Product Specifications
| Dosage | 60/400 mg |
| Formulation | Tablet |
| Packaging | 28 Tablets |
| Active Ingredients | Sofosbuvir, Daclatasvir |
| Manufacturer | Zydus Heptiza |
| License | Gilead Sciences |
| Usage | Treats chronic Hepatitis C, reduces viral load and manages liver damage |
| Features | Hepatitis C treatment, Liver protection, Viral reduction, Disease control |
| FOB Port | Delhi |
| Payment Terms | Cash Advance (CA), Paypal, Cash Against Delivery (CAD), Cash in Advance (CID) |
| Delivery Time | 5 Days |
| Sample Policy | Contact us for information regarding our sample policy |
Product Overview
Key Features
Hepatitis C is an irresistible malady influencing basically the liver, caused by the Hepatitis C Virus (HCV). It spreads basically through blood-to-blood contact related with inadequately sanitized therapeutic hardware, and transfusions. An expected 150 200 million individuals worldwide are contaminated with hepatitis C.
Company Details
Business Type
Exporter, Supplier, Trading Company
Employee Count
30
Establishment
2019
Working Days
Monday To Saturday
GST NO
05AANCM0640C1ZX
Payment Mode
Cash on Delivery (COD), Cash in Advance (CID)
More Product From This seller
Seller Details
GST - 05AANCM0640C1ZX
Dehradun, Uttarakhand
Director
Mr. Shubham Agrawal
Address
B No. - 18 P.D. Tandon Marg, Laxman Chowk, Dehradun, Uttarakhand, 248001, India
Report incorrect details



















